Investigative Ophthalmology & Visual Science

Investigative Ophthalmology & Visual Science
source
Title	Investigative Ophthalmology & Visual Science
Discipline	Ophthalmology
Abbreviation	IOVS
Publisher	Association for Research in Vision and Ophthalmology
Country	United States
Frequency	Monthly
History	1962–present
Impact	5.0

Investigative Ophthalmology & Visual Science Investigative Ophthalmology & Visual Science is a peer-reviewed journal publishing research in ophthalmology and vision science. The journal is associated with major organizations and institutions and appears in listings alongside journals from publishers and societies such as Nature Publishing Group, Elsevier, Wolters Kluwer, Springer Nature, Oxford University Press, John Wiley & Sons, Cambridge University Press, American Medical Association, American Academy of Ophthalmology, European Society of Retina Specialists, Royal College of Ophthalmologists, Kaiser Permanente, Mayo Clinic, Cleveland Clinic, Johns Hopkins University, Harvard Medical School, Stanford University School of Medicine, Massachusetts Eye and Ear Infirmary.

History and Publication Details

The journal was founded amid the postwar growth of specialized biomedical journals alongside titles such as The Lancet, New England Journal of Medicine, JAMA, BMJ, Annals of Internal Medicine, Nature Medicine, Science Translational Medicine, Proceedings of the National Academy of Sciences, Cell, Neuron, The American Journal of Ophthalmology, British Journal of Ophthalmology, Acta Ophthalmologica, Graefe's Archive for Clinical and Experimental Ophthalmology. Early editorial leadership included figures associated with institutions like University of Iowa, University of California, San Francisco, Columbia University, Yale University, University of Pennsylvania, University of Michigan, University of Wisconsin–Madison, Duke University, Emory University, Vanderbilt University Medical Center, Mount Sinai Health System, University of Chicago. Over decades the journal adapted publishing models similar to PLOS, BMJ Open, and transitioned alongside digital platforms developed by PubMed, MEDLINE, Scopus, Web of Science, CrossRef, ORCID, DOAJ.

Scope and Aims

The journal covers clinical and experimental studies in retinal research, cornea, glaucoma, ocular immunology, and visual neuroscience, aligning with research themes found at conferences such as ARVO Annual Meeting, Society for Neuroscience Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), European Society of Cataract and Refractive Surgeons (ESCRS), Asia-Pacific Academy of Ophthalmology (APAO), American Society of Retina Specialists (ASRS), International Council of Ophthalmology (ICO), World Health Organization initiatives. It seeks submissions that relate to diagnostics, therapeutics, imaging, and genetics, paralleling work from groups at Broad Institute, Wellcome Trust Sanger Institute, National Institutes of Health, National Eye Institute, Howard Hughes Medical Institute, Howard Hughes Medical Institute, European Molecular Biology Laboratory, Cancer Research UK, Karolinska Institutet, Max Planck Society. The aims reflect translational priorities similar to those promoted by Bill & Melinda Gates Foundation, Wellcome Trust, Chan Zuckerberg Initiative, National Science Foundation, European Research Council, Horizon 2020.

Editorial Structure and Peer Review

Editorial operations mirror governance models used by The Royal Society, National Academy of Sciences, American Association for the Advancement of Science, Institute of Medicine, Academy of Medical Sciences, European Molecular Biology Organization, Committee on Publication Ethics, International Committee of Medical Journal Editors, Council of Science Editors. An editor-in-chief is supported by associate editors and an editorial board drawn from investigators at Massachusetts Institute of Technology, California Institute of Technology, Imperial College London, University College London, King's College London, University of Oxford, University of Cambridge, ETH Zurich, University of Toronto, McGill University, Peking University Health Science Center, Tsinghua University, Seoul National University College of Medicine, Tokyo Medical and Dental University, Sungkyunkwan University, National University of Singapore. Peer review uses single- or double-blind models and sometimes open review formats inspired by practices at eLife, F1000Research, and incorporates statistical review similar to policies at The BMJ and JAMA.

Abstracting, Indexing, and Impact

The journal is indexed in databases and services such as PubMed, MEDLINE, Embase, Scopus, Web of Science, CINAHL, Google Scholar, CrossRef, Dimensions, Clarivate Analytics, InCites, SCImago Journal Rank, Eigenfactor. Impact metrics are reported alongside metrics for journals like Ophthalmology, American Journal of Ophthalmology, JAMA Ophthalmology, Retina, Investigative Ophthalmology & Visual Science-peer titles in citation reports produced by Clarivate, Elsevier, SCImago, Altmetric aggregators. The journal's reach is reflected in citations from researchers at National Institutes of Health, European Commission, Canadian Institutes of Health Research, Australian Research Council, Swiss National Science Foundation, Japanese Society for the Promotion of Science.

Notable Research and Contributions

Published work includes studies on retinal degeneration, gene therapy, optical coherence tomography, corneal transplantation, intraocular pressure physiology, and visual cortex plasticity, with contributions cited alongside landmark studies from Francis Crick, Santiago Ramón y Cajal, Stephen Kuffler, Hubel and Wiesel, Roger Sperry, David Hubel, Torsten Wiesel, Alfredo Quiñones-Hinojosa, Susumu Tonegawa, Shinya Yamanaka, Jennifer Doudna, Emmanuelle Charpentier, Feng Zhang, James Watson, Francis Crick-era references and modern teams at Broad Institute, Wellcome Sanger Institute, NIH Clinical Center, Massachusetts Eye and Ear, Bascom Palmer Eye Institute, Wills Eye Hospital, Moorfields Eye Hospital, Bascom Palmer Eye Institute-affiliated centers. Breakthrough reports have paralleled discoveries announced by CRISPR Therapeutics, Editas Medicine, Spark Therapeutics, Novartis, Roche, Regeneron Pharmaceuticals, Allergan, Bausch + Lomb, Alcon.

Access, Licensing, and Distribution

Distribution models have evolved from print subscriptions comparable to Pergamon Press and Elsevier catalogs to online open access options following policies from Plan S, Wellcome Trust, NIH Public Access Policy, European Research Council, cOAlition S. Licensing choices include traditional subscription, hybrid, and fully open-access arrangements with Creative Commons licenses analogous to those used by PLOS, BioMed Central, Frontiers Media S.A., and archives mirrored in repositories like PubMed Central and institutional repositories at Harvard University, Stanford University, University of Oxford, University of Cambridge, University of Tokyo. International distribution leverages indexing and partnerships with societies including ARVO, ESCRS, ASRS, and institutional consortia such as Big Ten Academic Alliance, Association of American Universities, and national library networks like the Library of Congress and the British Library.

Category:Ophthalmology journals